|
Rob,
Induction chemotherapy is still occasionally used for patients prior to stem cell transplant, but it does not seem to be as common as it may have been in the past. I think the primary reason is that it can really weaken the patient prior to transplant and make recovery more difficult.
there are several studies out there, but many of them come to the conclusion that since resistant MDS or AML are difficult to push into a full remission, it may not be worth the added risk. the decision of course depends on many variables including age and health of the patient, and how aggressive the disease seems to be at the time.
__________________
MDS RCMD w/grade 2-3 fibrosis. Allo-MUD Feb 26, 2014. Relapsed August 2014. Free and clear of MDS since November 2014 after treatment with Vidaza and Rituxan. Experiencing autoimmune attack on CNS thought to be GVHD, some gut, skin and ocular cGVHD. Neuropathy over 80% of body.
|